Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tate & Lyle Plc (TATE.LN)

Tate & Lyle Plc (TATE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,556,785
  • Shares Outstanding, K 401,694
  • Annual Sales, $ 1,751 M
  • Annual Income, $ 190,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.47
  • Price/Cash Flow 22.65
  • Price/Book 2.11
Trade TATE.LN with:
  • Price/Earnings ttm 14.84
  • Earnings Per Share ttm 0.43
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.19 (3.03%)
  • Most Recent Dividend 0.062 on 11/23/23
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
590.000 +8.05%
on 03/25/24
648.000 -1.62%
on 04/12/24
+34.500 (+5.72%)
since 03/19/24
3-Month
587.000 +8.60%
on 03/08/24
648.000 -1.62%
on 04/12/24
+20.000 (+3.24%)
since 01/19/24
52-Week
587.000 +8.60%
on 03/08/24
837.500 -23.88%
on 05/05/23
-162.000 (-20.26%)
since 04/19/23

Most Recent Stories

More News
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production

REDWOOD CITY, Calif. and HOFFMANN ESTATES, Ill., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Tate...

TATE.LN : 637.500 (+0.16%)
CDXS : 2.83 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 652.667
2nd Resistance Point 646.833
1st Resistance Point 642.167
Last Price 637.500
1st Support Level 631.667
2nd Support Level 625.833
3rd Support Level 621.167

See More

52-Week High 837.500
Fibonacci 61.8% 741.809
Fibonacci 50% 712.250
Fibonacci 38.2% 682.691
Last Price 637.500
52-Week Low 587.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar